Clinical trial

The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal…

NCT00235976 · Avera Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00235976
Title The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia
Official title A Multicenter, Randomized, Controlled, Observer-Blinded, Dose-Response Study to Evaluate the Efficacy in Tracheal Intubation and Safety of Gantacurium Chloride for Injection in Healthy Adult Patients Undergoing Surgery With General Anesthesia
Lead sponsor Avera Pharmaceuticals, Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Healthy
Intervention type Drug
Interventions Gantacurium Chloride for Injection (AV430A)
Enrollment 200
Start date May 1, 2005
Completion Mar 1, 2006
First posted Oct 12, 2005
Last update posted Jul 21, 2006
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies